- Home
- KBH vs PRCT Comparison
KBH vs PRCT Comparison
Compare KBH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBH
- PRCT
- Stock Information
- Founded
- KBH 1957
- PRCT 2009
- Country
- KBH United States
- PRCT United States
- Employees
- KBH N/A
- PRCT N/A
- Industry
- KBH Homebuilding
- PRCT Medical Specialities
- Sector
- KBH Consumer Discretionary
- PRCT Health Care
- Exchange
- KBH Nasdaq
- PRCT Nasdaq
- Market Cap
- KBH 5.7B
- PRCT 5.3B
- IPO Year
- KBH 1987
- PRCT 2021
- Fundamental
- Price
- KBH $79.39
- PRCT $93.60
- Analyst Decision
- KBH Hold
- PRCT Strong Buy
- Analyst Count
- KBH 14
- PRCT 6
- Target Price
- KBH $76.61
- PRCT $89.50
- AVG Volume (30 Days)
- KBH 983.8K
- PRCT 1.2M
- Earning Date
- KBH 01-08-2025
- PRCT 10-28-2024
- Dividend Yield
- KBH 1.26%
- PRCT N/A
- EPS Growth
- KBH 1.64
- PRCT N/A
- EPS
- KBH 7.79
- PRCT N/A
- Revenue
- KBH $6,604,175,000.00
- PRCT $199,843,000.00
- Revenue This Year
- KBH $9.04
- PRCT $67.06
- Revenue Next Year
- KBH $6.47
- PRCT $40.59
- P/E Ratio
- KBH $10.19
- PRCT N/A
- Revenue Growth
- KBH N/A
- PRCT 71.71
- 52 Week Low
- KBH $51.53
- PRCT $33.45
- 52 Week High
- KBH $89.70
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- KBH 49.12
- PRCT 57.39
- Support Level
- KBH $75.87
- PRCT $85.75
- Resistance Level
- KBH $83.40
- PRCT $95.36
- Average True Range (ATR)
- KBH 1.96
- PRCT 4.38
- MACD
- KBH -0.02
- PRCT -0.61
- Stochastic Oscillator
- KBH 46.75
- PRCT 43.47
About KBH KB Home
KB Home is an American construction company that focuses on residential construction in United States. The company builds single-family homes and communities across different geographical segments which include West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.